Authors: VALONE FH KAUFMAN PA GUYRE PM LEWIS LD MEMOLI V DEO Y GRAZIANO R FISHER JL MEYER L MROZEKORLOWSKI M WARDWELL K GUYRE V MORLEY TL ARVIZU C FANGER MW

Citation: Fh. Valone et al., PHASE IA IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU/, Journal of clinical oncology, 13(9), 1995, pp. 2281-2292